Elite Pharmaceuticals(ELTP)
$0.240.00 (0.00%)
ELTP
Elite Pharmaceuticals Revenue
$0.24
At close:0.00 (0.00%)
Want to see ELTP full AI Analyst Report?
Elite Pharmaceuticals (ELTP) Revenue
378 Followers
Elite Pharmaceuticals Revenue
Elite Pharmaceuticals had a revenue of 32.36M in the quarter ending Jun 30, 2026, with -20.60%. This bring the company's revenue in the last twelve months to 141.01M, Decreased 5.28%. In the fiscal year ending Mar 31, 2026, Elite Pharmaceuticals had annual revenue of 148.87M with 77.13% growth.
- Revenue (ttm)
- 141.01M
- Revenue Growth
- 33.72%
- P/S Ratio
- 1.74
- Revenue/Employee
- $2,290,310
- Employees
- 65
- Market Cap
- $258.51M
Revenue Chart
Elite Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 148.87M | 64.83M | 77.13% |
| Jun 30, 2025 | 84.04M | 27.42M | 48.42% |
| Jun 30, 2024 | 56.63M | 22.47M | 65.79% |
| Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
| Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
| Mar 31, 2021 | 25.38M | 7.39M | 41.05% |
| Mar 31, 2020 | 17.99M | 10.43M | 137.76% |
| Mar 31, 2019 | 7.57M | 109.80K | 1.47% |
| Mar 31, 2018 | 7.46M | -2.18M | -22.61% |
| Mar 31, 2017 | 9.64M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.